Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. - Wikidata - wikimedia - TriplyDB

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.

http://www.wikidata.org/entity/Q46533399

about

Temperature and toxic Tau in Alzheimer's disease: new insights NMR Meets Tau: Insights into Its Function and Pathology Mouse Genetic Models of Human Brain Disorders Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits Tau physiology and pathomechanisms in frontotemporal lobar degeneration Tau Biology and Tau-Directed Therapies for Alzheimer's Disease Tau Structures Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members Aggregation prone regions in human proteome: Insights from large-scale data analyses.Roles of tau protein in health and disease.Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.Phosphoregulation of Tau modulates inhibition of kinesin-1 motility.Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau-/- mice.Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.Development of an in-vivo active reversible butyrylcholinesterase inhibitor.Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau's interaction with microtubules in axon-like processes.A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.The use of human neurons for novel drug discovery in dementia research.Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes.SIRT1 Overexpression in Mouse Hippocampus Induces Cognitive Enhancement Through Proteostatic and Neurotrophic Mechanisms.Physiological and Pathophysiological Implications of Synaptic Tau.Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease Detergents: Friends not foes for high-performance membrane proteomics toward precision medicine.Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins.Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.Therapeutic Strategies for Restoring Tau Homeostasis.

P2860

Q26745778-B9F4DFE1-B839-46C4-9E9A-F111F27BE014 Q26747418-52695104-8B50-4016-AD84-EA270889FFC0 Q26752246-A419CF35-8D63-4363-A388-9D4BE6A0BA03 Q27314989-41054625-FD7B-45CB-BA7C-8E8BE5C85FB1 Q28070250-CC3F2BDD-FE97-4532-AFCC-9EB3400D5C77 Q28071398-DC5ACF5D-8927-4349-974F-3CFC3F0B7C74 Q28076921-C61DF8AF-A20C-45EF-8ACC-C066F2E6C67C Q28552366-20F8D582-D374-48CB-BF16-E11BA65CD157 Q28555169-49A9FD73-8511-4600-A238-A25B4126C266 Q31170430-A0E50988-7E97-407A-A064-E7B2DEF01F88 Q33559303-AC7ADA0D-B9A8-408F-9D73-DF9C4A3E5E3B Q33559307-8ABE6092-B2AE-4913-96D9-DC55EEA94A7D Q33563366-BAA9A2A9-957F-425A-A009-29B041620F95 Q33593280-2990AC10-CEA7-4D0D-B722-7C66DF1D6AB5 Q33706940-B958C7E0-5F2F-4FF6-9E10-B65EAE8AB965 Q33709279-F2CCE209-BAD8-48D5-8D4B-A4CB23CFDB87 Q34506149-E6A015FC-B402-4C48-8766-C0B19B4D1142 Q36639242-560BD3BE-83DC-42E5-9069-B6F9207DB3BE Q36755114-6FCE3F1C-5CAF-4948-9871-A655DEB231AB Q36877497-8D571BA2-F5B1-4C9A-A30B-1427A288BD1B Q37130046-C297831B-30FD-4965-89EB-BEC222CACF87 Q37515094-11A4E6A5-DB6F-4E0E-A5AF-9E8FA2493717 Q37522451-B05537CA-1D6F-444C-A98B-614DF21E2170 Q37549786-8789BB75-4179-49E1-B77B-F5FD679546FE Q37572010-64DB0D8F-2850-45DD-98DE-A2BF7DC1F13B Q37573270-1EA541A5-F00F-457E-90F7-17B56565D3B7 Q37695237-C5BF1C93-D7F3-49E1-AC6E-2758BAF73486 Q38640294-64142221-0BE2-4C91-901E-29AF89F1E211 Q38683819-B64B1CBC-FAFB-4BB9-B51B-9DC7C4D0FFC7 Q38734115-2AD583A2-7832-466A-BCD1-BBC25671CFBB Q38736515-EEA048B2-6403-43D4-B802-82B7C378E2D5 Q38747012-E9CC34A2-5388-41D0-9F74-CC1C1519BB43 Q38747530-227A45E8-D569-40FD-B9FC-2C84665B3ED5 Q38788038-758D9E69-3658-4B37-9181-F6FFBB11E3C9 Q38955724-1063F9AD-D167-4A95-ADBC-06B97454E457 Q38983187-A7206BB9-AB37-4772-9817-B0AC77926153 Q39035486-106751FC-1291-4690-B28C-BBD759927AFF Q39036047-A9AA6B6A-8F41-48B2-83AB-E68ECB960992 Q39085129-A53AFC43-C3DA-4A3B-A7E3-40F0F10467BC Q39118898-D113809A-294E-4C97-8491-489BDAF8D053

P2860

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice.

http://www.wikidata.org/entity/Q46533399

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Tau post-translational modific ...... ursor protein transgenic mice.

@en

Tau post-translational modific ...... ursor protein transgenic mice.

@nl

type

label

Tau post-translational modific ...... ursor protein transgenic mice.

@en

Tau post-translational modific ...... ursor protein transgenic mice.

@nl

prefLabel

Tau post-translational modific ...... ursor protein transgenic mice.

@en

Tau post-translational modific ...... ursor protein transgenic mice.

@nl

P1433

Q46533399-D6092926-04E6-4016-8830-2CBF0AEE3BA4

P1476

Q46533399-019FED18-5832-427F-A8E6-BDF0C6AC6F35

P2093

Q46533399-4CE273F3-0CB7-4DC3-B4AB-7B22D234E2B3

Q46533399-75ABF1D2-5F92-4833-B727-81EB5F9D0FCB

Q46533399-79CAA94B-B659-4752-A3F8-75B83EA8AA35

Q46533399-82A732FA-BBFD-4472-9F9A-FDA63FE4B7A2

Q46533399-8CFD7DB0-3910-4752-87FA-0A7DF9D986C1

P2860

Q46533399-0C82FD49-0070-4620-B1A3-6B45AD7CE6BF

Q46533399-0D356AD3-DA1F-434A-AB87-20666E1DCCC4

Q46533399-193F925A-06B7-46A7-ABB9-A814BE8C20E2

Q46533399-1A588BAC-9243-4DF7-9A4A-BA7CDEC8DC11

Q46533399-1D01668E-4267-4FD8-8258-A5113AF07538

Q46533399-36E43105-268E-40DE-895F-C1DDA51C9B8E

Q46533399-3A067FAE-B214-4D29-9ADD-392A99C17D28

Q46533399-3B593FB1-662C-4D9E-99E4-C42D35C3D1CB

Q46533399-3D1E1196-FE34-42E9-A15E-67F54B961BF8

Q46533399-4F16F928-ACF3-4745-828E-5BCEED9FFC3D

P2888

Q46533399-CF25F21F-2395-41A2-858B-1A1DD2579107

P304

Q46533399-16C80F5D-3184-42C7-A0A8-3FEE0EB8E5D2

P31

Q46533399-7FD4A0FE-C288-4D43-98B6-CC01017BE9B9

P356

Q46533399-B1F15F1F-8931-42FE-A735-742E58CDD472

P407

Q46533399-5A1FA3D6-4388-4753-8F9E-BF906DC6E62E

P433

Q46533399-52CAC99D-AB68-4FD8-8D65-F042894E863A

P478

Q46533399-6CFBFB14-AC02-4FF5-9BBC-045FB99773CE

P50

Q46533399-8A4CE6C6-E356-49DE-9202-9E7D41674364

Q46533399-C12A463B-8787-4B8F-ABD2-6B7BCC43F83C

P577

Q46533399-C791C893-5206-4A32-BA46-8202D1C3D167

P698

Q46533399-EFF4F738-CF8C-4EA0-9D4B-1079E7F85BDD

P356

P1433

Nature Neuroscience

P1476

Tau post-translational modific ...... ursor protein transgenic mice.

@en

P2093

Alexandra Ioanoviciu

http://www.w3.org/2001/XMLSchema#string

Alma L Burlingame

http://www.w3.org/2001/XMLSchema#string

Giselle M Knudsen

http://www.w3.org/2001/XMLSchema#string

Jonathan C Trinidad

http://www.w3.org/2001/XMLSchema#string

Lennart Mucke

http://www.w3.org/2001/XMLSchema#string

P2860

A probability-based approach for high-throughput protein phosphorylation analysis and site localization

Alzheimer mechanisms and therapeutic strategies

Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs

Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Lysine acetylation: codified crosstalk with other posttranslational modifications

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

Nuclear tau, a key player in neuronal DNA protection.

P2888

P304

1183-1189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN.4067

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26192747

http://www.w3.org/2001/XMLSchema#string